OTCPK:CANV.F

Stock Analysis Report

Executive Summary

Eurolife Brands Inc. operates as a business technology company within the health sciences sector in the United States and internationally.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Eurolife Brands has significant price volatility in the past 3 months.
  • Eurolife Brands is not covered by any analysts.

Share Price & News

How has Eurolife Brands's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-14.7%

CANV.F

0.9%

US Healthcare Services

-0.2%

US Market


1 Year Return

n/a

CANV.F

8.7%

US Healthcare Services

1.1%

US Market

No trading data on CANV.F.

No trading data on CANV.F.


Share holder returns

CANV.FIndustryMarket
7 Day-14.7%0.9%-0.2%
30 Day-21.4%-5.2%2.5%
90 Day77.7%-5.5%1.6%
1 Yearn/a8.8%8.7%3.4%1.1%
3 Yearn/a49.7%49.4%45.2%35.8%
5 Yearn/a50.3%49.4%62.6%44.8%

Price Volatility Vs. Market

How volatile is Eurolife Brands's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Eurolife Brands undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Eurolife Brands is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Eurolife Brands has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of CANV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Eurolife Brands regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Eurolife Brands expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eurolife Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of CANV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Eurolife Brands's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Eurolife Brands performed over the past 5 years?

-96.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Eurolife Brands does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Eurolife Brands's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Eurolife Brands's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Eurolife Brands has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Eurolife Brands has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Eurolife Brands improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Eurolife Brands's financial position?


Financial Position Analysis

Eurolife Brands's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Eurolife Brands has no long term commitments.


Debt to Equity History and Analysis

Eurolife Brands has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Eurolife Brands's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Eurolife Brands has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Eurolife Brands has less than a year of cash runway based on current free cash flow.

Eurolife Brands has less than a year of cash runway if free cash flow continues to grow at historical rates of 109.6% each year.


Next Steps

Dividend

What is Eurolife Brands's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Eurolife Brands's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Eurolife Brands's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Eurolife Brands has not reported any payouts.

Unable to verify if Eurolife Brands's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Eurolife Brands has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Eurolife Brands's salary, the management and board of directors tenure and is there insider trading?

1.1yrs

Average board tenure


CEO

Shawn Moniz 0

0yrs

Tenure

0

Mr. Shawn Moniz serves as the Chief Executive Officer and a Director of Cannvas MedTech Inc. As Chief Executive Officer, Mr. Moniz leads Cannvas MedTech Inc.’s strategic direction and overall firm-wide suc ...


Board Age and Tenure

1.1yrs

Average Tenure

The average tenure for the Eurolife Brands board of directors is less than 3 years, this suggests a new board.


Insider Trading

More shares have been bought than sold by Eurolife Brands individual insiders in the past 3 months.


Recent Insider Transactions

BuyCA$32,06830 Aug 19
Fusionworx Investment Group Inc.
EntityCompany
Shares414,000
Max PriceCA$0.079
BuyCA$3,46622 Aug 19
Fusionworx Investment Group Inc.
EntityCompany
Shares46,000
Max PriceCA$0.075
BuyCA$3,34219 Aug 19
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares32,900
Max PriceCA$0.10
BuyCA$36,55516 Aug 19
FourOneSix Inc.
EntityCompany
Shares360,500
Max PriceCA$0.10
BuyCA$4,24416 Aug 19
Fusionworx Investment Group Inc.
EntityCompany
Shares43,500
Max PriceCA$0.098
BuyCA$250,36908 Aug 19
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares5,800,000
Max PriceCA$0.043
BuyCA$250,36908 Aug 19
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares5,800,000
Max PriceCA$0.043
BuyCA$121,99424 Jul 19
Fusionworx Investment Group Inc.
EntityCompany
Shares2,848,000
Max PriceCA$0.052
BuyCA$3,83417 Jul 19
Lindsay Hamelin
EntityIndividual
Role
Member of the Board of Directors
Director
Shares100,000
Max PriceCA$0.038
BuyCA$19,17017 Jul 19
FourOneSix Inc.
EntityCompany
Shares500,000
Max PriceCA$0.038
BuyCA$19,17017 Jul 19
Fusionworx Investment Group Inc.
EntityCompany
Shares500,000
Max PriceCA$0.038
BuyCA$96906 Mar 19
FourOneSix Inc.
EntityCompany
Shares22,000
Max PriceCA$0.044
BuyCA$2,85415 Feb 19
Fusionworx Investment Group Inc.
EntityCompany
Shares56,000
Max PriceCA$0.051
BuyCA$4,67215 Feb 19
FourOneSix Inc.
EntityCompany
Shares92,000
Max PriceCA$0.051
BuyCA$2,81913 Feb 19
FourOneSix Inc.
EntityCompany
Shares52,000
Max PriceCA$0.054
BuyCA$24,17807 Feb 19
FourOneSix Inc.
EntityCompany
Shares410,000
Max PriceCA$0.062
BuyCA$2,78601 Feb 19
FourOneSix Inc.
EntityCompany
Shares50,000
Max PriceCA$0.056
BuyCA$8,13401 Feb 19
Fusionworx Investment Group Inc.
EntityCompany
Shares154,000
Max PriceCA$0.053
BuyCA$19,79925 Jan 19
Lindsay Hamelin
EntityIndividual
Role
Member of the Board of Directors
Director
Shares350,000
Max PriceCA$0.057
BuyCA$112,85421 Jan 19
FourOneSix Inc.
EntityCompany
Shares2,000,000
Max PriceCA$0.056
BuyCA$3,76221 Jan 19
Miroslav Beganovic
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares66,668
Max PriceCA$0.056
BuyCA$112,85421 Jan 19
Fusionworx Investment Group Inc.
EntityCompany
Shares2,000,000
Max PriceCA$0.056
BuyCA$48314 Jan 19
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares8,000
Max PriceCA$0.06
BuyCA$4,63711 Jan 19
FourOneSix Inc.
EntityCompany
Shares78,000
Max PriceCA$0.059
BuyCA$7,06209 Jan 19
FourOneSix Inc.
EntityCompany
Shares120,000
Max PriceCA$0.062
BuyCA$42501 Jan 19
FourOneSix Inc.
EntityCompany
Shares8,000
Max PriceCA$0.053
BuyCA$82228 Dec 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares17,872
Max PriceCA$0.046
BuyCA$5,95925 Dec 18
FourOneSix Inc.
EntityCompany
Shares126,000
Max PriceCA$0.053
BuyCA$35213 Dec 18
FourOneSix Inc.
EntityCompany
Shares6,000
Max PriceCA$0.059
BuyCA$4,81910 Dec 18
FourOneSix Inc.
EntityCompany
Shares92,000
Max PriceCA$0.053
BuyCA$2,79107 Dec 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares60,000
Max PriceCA$0.047
BuyCA$7,44207 Dec 18
Fusionworx Investment Group Inc.
EntityCompany
Shares160,000
Max PriceCA$0.047
BuyCA$1,77706 Dec 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares36,000
Max PriceCA$0.051
BuyCA$2,17305 Dec 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares40,000
Max PriceCA$0.056
BuyCA$71703 Dec 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares12,000
Max PriceCA$0.062
BuyCA$6,23626 Nov 18
FourOneSix Inc.
EntityCompany
Shares100,000
Max PriceCA$0.062
BuyCA$1,40722 Nov 18
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares24,000
Max PriceCA$0.059
BuyCA$3,99122 Nov 18
FourOneSix Inc.
EntityCompany
Shares66,000
Max PriceCA$0.062
BuyCA$1,72621 Nov 18
Fusionworx Investment Group Inc.
EntityCompany
Shares28,000
Max PriceCA$0.062
BuyCA$178,35320 Nov 18
Fusionworx Investment Group Inc.
EntityCompany
Shares3,000,000
Max PriceCA$0.059
BuyCA$1,46820 Nov 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares24,000
Max PriceCA$0.062
BuyCA$6,35419 Nov 18
Fusionworx Investment Group Inc.
EntityCompany
Shares100,000
Max PriceCA$0.064
BuyCA$2,60614 Nov 18
FourOneSix Inc.
EntityCompany
Shares40,000
Max PriceCA$0.066
BuyCA$41709 Nov 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares6,000
Max PriceCA$0.07
BuyCA$2,80808 Nov 18
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares42,000
Max PriceCA$0.07
BuyCA$14107 Nov 18
Shawn Moniz
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares2,000
Max PriceCA$0.071
BuyCA$1,48131 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares20,000
Max PriceCA$0.074
BuyCA$3,60531 Oct 18
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares48,000
Max PriceCA$0.075
BuyCA$20323 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares2,800
Max PriceCA$0.073
BuyCA$1,19022 Oct 18
FourOneSix Inc.
EntityCompany
Shares16,000
Max PriceCA$0.074
BuyCA$2,88418 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares30,000
Max PriceCA$0.096
BuyCA$1,73810 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares20,000
Max PriceCA$0.087
BuyCA$3,61810 Oct 18
FourOneSix Inc.
EntityCompany
Shares40,000
Max PriceCA$0.091
BuyCA$2,47509 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares28,000
Max PriceCA$0.089
BuyCA$4,49705 Oct 18
Fusionworx Investment Group Inc.
EntityCompany
Shares50,400
Max PriceCA$0.09
BuyCA$13,15705 Oct 18
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares148,000
Max PriceCA$0.091
BuyCA$7,14925 Sep 18
FourOneSix Inc.
EntityCompany
Shares100,000
Max PriceCA$0.071
BuyCA$71525 Sep 18
Steve Loutskou
EntityIndividual
Role
Member of the Board of Directors
Chief Operating Officer of Global Markets & Director
Shares10,000
Max PriceCA$0.071
BuyCA$30224 Sep 18
Fusionworx Investment Group Inc.
EntityCompany
Shares4,000
Max PriceCA$0.075
BuyCA$8,92724 Sep 18
FourOneSix Inc.
EntityCompany
Shares120,000
Max PriceCA$0.075

Ownership Breakdown


Management Team

  • Shawn Moniz

    CEO & Director

    • Tenure: 0yrs
  • Steve Loutskou

    Chief Operating Officer of Global Markets & Director

    • Tenure: 0yrs
  • Miroslav Beganovic

    Chief Financial Officer

    • Tenure: 1.4yrs
  • Marco Contardi

    Director & Corporate Counsel

    • Tenure: 1.4yrs
  • Radu Puscasu

    Vice President of Technology

    • Tenure: 0yrs

Board Members

  • Derek Lloyd Ivany

    Chairman of the Advisory Board

    • Tenure: 0yrs
  • Shawn Moniz

    CEO & Director

    • Tenure: 0yrs
  • Steve Loutskou

    Chief Operating Officer of Global Markets & Director

    • Tenure: 0yrs
  • Marco Contardi

    Director & Corporate Counsel

    • Tenure: 1.4yrs
  • Lindsay Hamelin

    Director

    • Tenure: 1.4yrs
  • Daniel Bal

    Member of the Medical Advisory Board

    • Tenure: 1.2yrs
  • Shirish Patel

    Member of the Medical Advisory Board

    • Tenure: 1.1yrs
  • Stacey Paterson

    Member of the Medical Advisory Board

    • Tenure: 1.1yrs
  • Angela Smith

    Member of Cannabis Sciences Advisory Board

    • Tenure: 0.7yrs
  • Emma Chasen

    Member of Cannabis Sciences Advisory Board

    • Tenure: 0.6yrs

Company Information

Eurolife Brands Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Eurolife Brands Inc.
  • Ticker: CANV.F
  • Exchange: OTCPK
  • Founded: 2014
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$38.417m
  • Listing Market Cap: CA$28.994m
  • Shares outstanding: 349.25m
  • Website: https://www.eurolifebrands.com

Location

  • Eurolife Brands Inc.
  • 750 West Pender Street
  • Suite 804
  • Vancouver
  • British Columbia
  • V6C 2T7
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EUROCNSX (Canadian National Stock Exchange)YesCommon SharesCACADJul 2018
3CMADB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2018
CANV.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 2018

Biography

Eurolife Brands Inc. operates as a business technology company within the health sciences sector in the United States and internationally. It operates Cannvas.Me, a platform that provides accessible and ev ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:57
End of Day Share Price2019/09/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.